07:30 AM EST, 01/08/2025 (MT Newswires) -- Merck ( MRK ) said Wednesday that China's National Medical Products Administration has approved the Gardasil vaccine against human papillomavirus, or HPV, for use in males 9 to 26 years old to prevent HPV-related cancers and diseases.

The company said the approval expands Gardasil's indication in China, in addition to the prevention of anal cancers caused by HPV Types 16 and 18, genital warts caused by HPV Types 6 and 11, and certain precancerous or dysplastic lesions caused by HPV.